[1]
Sameh Saber, Amr A. A. Mahmoud, Noha S. Helal, Eman El-ahwany, and Rasha H. Abdelghany, “Losartan, an angiotensin-II type 1 receptor blocker, attenuates CCl4-induced liver fibrosis with a positive impact on survival in mice”, World J Pharm Sci, vol. 5, no. 12, pp. 121–126, Dec. 2017.